Cardiogenic shock is one of the most serious complications of acute myocardial infarction with an incidence rate of 7% to 10%. In recent years, with the development of revascularization techniques, such as percutanous coronary intervention (PCI) and coronary artery bypass grafting (CABG), the effective cooperation of dopamine and intraaortic balloon pumping (IABP), and the application of new drug-levosimendan, and mechanical circulatory assist devices, ventricular assist device (VAD) and extracorporeal membrane oxygenation (ECMO), the mortality rate has declined from 70%-80% in 1970s to 50% now. In this paper, we summarized the diagnostic criteria, pathophysiology and interventional measures for cardiogenic shock secondary to acute myocardial infarction.